Ensartinib Interactions
There are 257 drugs known to interact with ensartinib. Of the total drug interactions, 9 are major, and 248 are moderate.
Medications known to interact with ensartinib
Note: Showing generic names only.
- abametapir topical
- abiraterone
- abrocitinib
- acarbose
- acetohexamide
- adagrasib
- albiglutide
- alectinib
- alemtuzumab
- alogliptin
- alpelisib
- aminolevulinic acid
- aminolevulinic acid topical
- amiodarone
- amprenavir
- apalutamide
- aprepitant
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- astemizole
- atazanavir
- avacopan
- azithromycin
- bedaquiline
- belzutifan
- bepridil
- berotralstat
- bexagliflozin
- bexarotene
- black cohosh
- boceprevir
- bosentan
- brentuximab
- brigatinib
- cabozantinib
- calaspargase pegol
- canagliflozin
- cannabidiol
- capmatinib
- carbamazepine
- carvedilol
- cenobamate
- ceritinib
- chloramphenicol
- chlorpropamide
- cimetidine
- ciprofloxacin
- clarithromycin
- clofarabine
- clofazimine
- cobicistat
- conivaptan
- crizotinib
- cyclosporine
- dabrafenib
- daclatasvir
- daclizumab
- danazol
- danicopan
- dapagliflozin
- daridorexant
- darunavir
- delavirdine
- dexamethasone
- diltiazem
- diosmiplex
- dronedarone
- dulaglutide
- duvelisib
- echinacea
- efavirenz
- elacestrant
- elagolix
- eliglustat
- empagliflozin
- enasidenib
- encorafenib
- enzalutamide
- epirubicin
- erdafitinib
- ertugliflozin
- erythromycin
- eslicarbazepine
- etranacogene dezaparvovec
- etrasimod
- etravirine
- exenatide
- fedratinib
- felodipine
- fexinidazole
- fidanacogene elaparvovec
- fingolimod
- flibanserin
- fluconazole
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fosphenytoin
- fostamatinib
- futibatinib
- ibrutinib
- idelalisib
- imatinib
- indinavir
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- interferon beta-1a
- interferon beta-1b
- isavuconazonium
- isoniazid
- istradefylline
- itraconazole
- ivacaftor
- ivosidenib
- ixabepilone
- lapatinib
- lasmiditan
- lefamulin
- leflunomide
- lenacapavir
- letermovir
- levacetylleucine
- levoketoconazole
- lidocaine
- linagliptin
- liraglutide
- lixisenatide
- lomitapide
- lonafarnib
- lorlatinib
- maribavir
- mavorixafor
- metformin
- methotrexate
- methoxsalen
- methyl aminolevulinate topical
- mibefradil
- miconazole
- mifepristone
- miglitol
- mipomersen
- mirabegron
- mitapivat
- mitotane
- nafcillin
- naltrexone
- naproxen
- nateglinide
- nefazodone
- nelfinavir
- neratinib
- nevirapine
- nifedipine
- nilotinib
- nirogacestat
- pacritinib
- palbociclib
- pegaspargase
- peginterferon beta-1a
- pemigatinib
- pexidartinib
- phenobarbital
- phenytoin
- pioglitazone
- pirtobrutinib
- ponatinib
- ponesimod
- porfimer
- posaconazole
- pralsetinib
- pramlintide
- primidone
- progesterone
- propafenone
- ranolazine
- remdesivir
- repaglinide
- repotrectinib
- ribociclib
- rifabutin
- rifampin
- rifapentine
- ripretinib
- ritlecitinib
- ritonavir
- rolapitant
- rosiglitazone
- saquinavir
- sarecycline
- saxagliptin
- semaglutide
- simeprevir
- siponimod
- sitagliptin
- sorafenib
- sotagliflozin
- sotorasib
- sparsentan
- st. john's wort
- stiripentol
- suzetrigine
- tacrolimus
- tamoxifen
- telaprevir
- telithromycin
- tepotinib
- terfenadine
- teriflunomide
- testosterone
- thioguanine
- ticagrelor
- tirzepatide
- tolazamide
- tolbutamide
- tolvaptan
- trabectedin
- treosulfan
- trifluoperazine
- trimethoprim
- troglitazone
- troleandomycin
- tucatinib
- valoctocogene roxaparvovec
- vandetanib
- vemurafenib
- venetoclax
- verapamil
- verteporfin
- voclosporin
- voriconazole
- voxelotor
Report options
More about ensartinib
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Docetaxel
Docetaxel is used for breast cancer, breast cancer, metastatic, gastric cancer, head and neck ...
Nivolumab
Nivolumab is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Paclitaxel
Paclitaxel is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, kaposi's ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.